Your browser doesn't support javascript.
loading
Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.
Shimazu, Yutaka; Kanda, Junya; Kosugi, Satoru; Ito, Tomoki; Kaneko, Hitomi; Imada, Kazunori; Shimura, Yuji; Fuchida, Shin-Ichi; Fukushima, Kentaro; Tanaka, Hirokazu; Yoshihara, Satoshi; Ohta, Kensuke; Uoshima, Nobuhiko; Yagi, Hideo; Shibayama, Hirohiko; Yamamura, Ryosuke; Tanaka, Yasuhiro; Uchiyama, Hitoji; Onda, Yoshiyuki; Adachi, Yoko; Hanamoto, Hitoshi; Takahashi, Ryoichi; Matsuda, Mitsuhiro; Miyoshi, Takashi; Takakuwa, Teruhito; Hino, Masayuki; Hosen, Naoki; Nomura, Shosaku; Shimazaki, Chihiro; Matsumura, Itaru; Takaori-Kondo, Akifumi; Kuroda, Junya.
Afiliación
  • Shimazu Y; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, 54, Kawaramachi, Shogoin, Sakyoku, Kyoto, 606-8507, Japan.
  • Kanda J; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, 54, Kawaramachi, Shogoin, Sakyoku, Kyoto, 606-8507, Japan. jkanda16@kuhp.kyoto-u.ac.jp.
  • Kosugi S; Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Toyonaka, Japan.
  • Ito T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Kaneko H; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Fukushima K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tanaka H; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Higashiosaka, Japan.
  • Yoshihara S; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Ohta K; Hematology Ohta Clinic, Shinsaibashi, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Yagi H; Department of Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan.
  • Shibayama H; Department of Hematology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Yamamura R; Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Tanaka Y; Department of Hematology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
  • Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Onda Y; Department of Hematology, Japanese Red Cross Takatsuki Hospital, Takatsuki, Japan.
  • Adachi Y; Department of Internal Medicine, Japan Community Health Care Organization Kobe Central Hospital, Kobe, Japan.
  • Hanamoto H; Department of Hematology, Kindai University Nara Hospital, Ikoma, Japan.
  • Takahashi R; Department of Hematology, Omihachiman Community Medical Center, Omihachiman, Japan.
  • Matsuda M; Department of Hematology, PL General Hospital, Tondabayashi, Japan.
  • Miyoshi T; Department of Hematology, Uji Tokushukai Hospital, Uji, Japan.
  • Takakuwa T; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Hino M; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Hosen N; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nomura S; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Shimazaki C; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Matsumura I; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Higashiosaka, Japan.
  • Takaori-Kondo A; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, 54, Kawaramachi, Shogoin, Sakyoku, Kyoto, 606-8507, Japan.
  • Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sci Rep ; 13(1): 5159, 2023 03 29.
Article en En | MEDLINE | ID: mdl-36991096
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article